技术驱动 | 博腾与 Cognition Therapeutics 联合发表 OPRD 论文,彰显药物合成技术实力

博腾股份Porton
08 Jul

近期,Cognition Therapeutics研究团队在美国化学学会(American Chemical Society, ACS)权威刊物《Organic Process Research & Development》(OPRD)发表论文《基于光流技术与高通量筛选技术(HTS)的σ-2受体调节剂CT1812商业化合成路线开发》,博腾股份作为其CDMO合作企业之一,共同参与了此项目。作为工艺...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10